Literature DB >> 11742867

Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor.

S Yang1, X Xin, C Zlot, G Ingle, G Fuh, B Li, B Moffat, A M de Vos, M E Gerritsen.   

Abstract

Vascular endothelial cell growth factor (VEGF) binds to 2 related receptor tyrosine kinases, known as kinase insert domain-containing receptor (KDR) and fms-like tyrosine kinase (Flt-1). The KDR has been shown to mediate VEGF-stimulated endothelial cell mitogenesis, migration, and permeability. The Flt-1 receptor has been suggested to mediate VEGF-stimulated endothelial branching morphogenesis, a process whereby endothelial cells, in the presence of a 3D milieu composed of extracellular matrix components and a mixture of growth factors, undergo a morphological transition into a tubular network with many lumina. In the present study, we have used 2 independent endothelial cell tube formation models and highly selective VEGF mutants for the KDR and Flt-1 receptors. We demonstrate that KDR, not Flt-1, stimulation is responsible for the induction of endothelial tubulogenesis. In addition, we demonstrate a modulatory role for Flt-1 in VEGF-mediated tube formation. We also report that VEGF-driven endothelial tube formation is inhibited by selective inhibitors of mitogen-activated protein kinase activation and p38 protein kinase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742867     DOI: 10.1161/hq1201.099432

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  18 in total

1.  Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription.

Authors:  Guangqi E; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Enfeng Wang; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK.

Authors:  Tracy Dodd; Rashmi Jadhav; Luke Wiggins; James Stewart; Erika Smith; James C Russell; Petra Rocic
Journal:  J Mol Cell Cardiol       Date:  2011-08-22       Impact factor: 5.000

3.  Perfusable branching microvessel bed for vascularization of engineered tissues.

Authors:  Loraine L Y Chiu; Miles Montgomery; Yan Liang; Haijiao Liu; Milica Radisic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

4.  Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

Authors:  Yuhui Huang; Xiaolan Chen; Mikhail M Dikov; Sergey V Novitskiy; Claudio A Mosse; Li Yang; David P Carbone
Journal:  Blood       Date:  2007-03-21       Impact factor: 22.113

5.  p38 MAPK activity is stimulated by vascular endothelial growth factor receptor 2 activation and is essential for shear stress-induced angiogenesis.

Authors:  Eric Gee; Malgorzata Milkiewicz; Tara L Haas
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

6.  Differential effects of cyclic and static stretch on coronary microvascular endothelial cell receptors and vasculogenic/angiogenic responses.

Authors:  Wei Zheng; Lance P Christensen; Robert J Tomanek
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

7.  LY2228820 dimesylate, a selective inhibitor of p38 mitogen-activated protein kinase, reduces angiogenic endothelial cord formation in vitro and in vivo.

Authors:  Courtney M Tate; Wayne Blosser; Lisa Wyss; Glenn Evans; Qi Xue; Yong Pan; Louis Stancato
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

8.  Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice.

Authors:  Xiao-Bing Cui; Xia Guo; Shi-You Chen
Journal:  Cardiovasc Res       Date:  2013-05-21       Impact factor: 10.787

9.  In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts.

Authors:  S Kalkunte; Z Lai; N Tewari; C Chichester; R Romero; J Padbury; S Sharma
Journal:  Placenta       Date:  2008-09-04       Impact factor: 3.481

10.  Comparing the angiogenic potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells.

Authors:  Mo Dao; Ciara C Tate; Michael McGrogan; Casey C Case
Journal:  J Transl Med       Date:  2013-03-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.